Can Depakote Increase Pulse?
Yes, Depakote (valproic acid) can cause tachycardia (increased pulse), though this is not a common adverse effect at therapeutic doses.
Evidence from FDA Drug Labeling
The official FDA labeling for Depakote explicitly lists tachycardia as a cardiovascular adverse reaction, occurring in greater than 1% but less than 5% of patients treated with valproate in controlled trials of complex partial seizures 1. The drug label also documents palpitation and hypertension in the same frequency range, indicating that cardiovascular effects including increased heart rate do occur with this medication.
Context: When Does This Occur?
The relationship between Depakote and increased pulse appears most prominent in two clinical scenarios:
1. Overdose/Intoxication Settings
Tachycardia is a well-documented feature of valproic acid toxicity:
- A case report of severe VPA intoxication (plasma level 1,150 mg/L) documented atrial tachycardia as a presenting feature 2
- A pediatric overdose case (6,000 mg ingestion) demonstrated tachycardia during the acute toxic phase 3
- A comparative cohort study found tachycardia occurred in 5 out of 15 patients with valproate-only poisoning 4
2. Therapeutic Dosing
At standard therapeutic doses, tachycardia occurs but is relatively uncommon (1-5% incidence) 1. Importantly, one study specifically evaluating rapid IV infusion of valproate sodium (up to 6 mg/kg/minute) found no clinically significant negative effects on pulse rate 5, suggesting that the tachycardia seen in clinical practice may be related to other factors or individual patient susceptibility.
Clinical Implications
Monitor for tachycardia particularly in:
- Patients receiving high doses or experiencing toxicity (check valproate levels if tachycardia develops)
- Overdose situations where tachycardia may accompany other serious effects (CNS depression, metabolic acidosis, thrombocytopenia)
- Patients with pre-existing cardiac conditions
Important caveat: When tachycardia occurs in patients on Depakote who are also taking other medications (especially other antiepileptic drugs), it may be difficult to determine whether valproate alone is responsible 1. One case report suggested valproate may have precipitated neuroleptic malignant syndrome (which includes tachycardia) in a patient on antipsychotics 6.
Bottom Line
While tachycardia is a recognized adverse effect of Depakote per FDA labeling, it is relatively uncommon at therapeutic doses (1-5% incidence). It becomes more prominent in overdose situations. If a patient on Depakote develops new-onset tachycardia, check valproate levels, review concomitant medications, and evaluate for other causes of tachycardia before attributing it solely to valproate.